Dispatch
Insights for revenue cycle leaders
RCM trends, denial analysis, and operational strategy from the Exactrx team.
Initial denials fell in H1 2026, but payer takebacks rose 13.8%. Premier's 2023 figure of $57.23 per contested claim shows what fighting back costs.
One in five providers now report final denial rates above 5%. What two 2026 surveys and three policy moves say about where payer friction goes next.
Blue Cross says hospital AI coding added $942M in costs. Hospitals say payer AI buries them in denials. Both claims hold up.
Nashville-based AI medical billing company takes top prize at the state's largest entrepreneurship conference.
Audit data shows 40% of modifier 59 claims fail Medicare requirements; this data-driven guide covers proper use and the underpayment patterns hiding in claims.
Nearly 1 in 4 ASCs still charts on paper. Compare the top 10 ASC EMRs, how to evaluate them, and the 5 questions to ask before you sign.
Hospitals spent $18B fighting denials in 2025. AR days rose 5.2% anyway. Here's what the data says about why, and what to do.
The IDR admin fee drops 85% to $15 in August 2026. Here's how batching rules and a new registry reshape your dispute economics.
When 97% of appealed denials get overturned, the initial denial stops being clinical. Here's what that means for your RCM strategy.
Denial management is now one of the costliest jobs in the revenue cycle. The groups pulling ahead score claims for denial risk before they ever reach the payer.